Shares of medical technology company Affymetrix ( AFFX) gained more than 12% Monday after the company said it expects fourth-quarter revenue to exceed analysts' expectations.

The company says it should report sales of $100 million, compared with $99.47 million expected by analysts surveyed by Thomson First Call.

"During the fourth quarter, we delivered important new products to customers and announced several exciting commercial agreements," said CEO Stephen Fodor. "It was a quarter of solid performance."

Shares rose $2.46 to $24.18.

More from Stocks

Musk's The Boring Company Just Got a Bit Less Boring

Musk's The Boring Company Just Got a Bit Less Boring

Tyson Foods CEO: We Aren't Done Making Deals

Tyson Foods CEO: We Aren't Done Making Deals

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries

Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success

Warren Buffett at Age 87 Still Does One Amazing Thing That Drives Success

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June

Amazon, Nvidia, Micron and 10 Other Stocks to Own in June